Leadership Team

Mark Adams

Ph.D.

Professor & Interim Scientific Director, The Jackson Laboratory for Genomic Medicine

Leads the research and clinical genome sequencing groups.

Doug Abbott

M.B.A., C.P.A.

Senior Vice President and Chief Financial Officer

Doug provides strategic leadership, direction and management for all financial and risk management activities.

Brendan Arbuckle

Chief Information Officer

Leads all aspects of IT across JAX with a focus on advancing scientific research through technology.

LuAnn Ballesteros

Vice President, External and Government Affairs

​Shapes legislative and policy agendas at federal, state and local levels.

Brian Bannerman

Vice President, JMCRS Finance

Provides decision support, direction and management for JMCRS.

Madeleine Braun

Ph.D., MBA

Vice President, Research Growth Initiatives

Responsible for planning and implementation of operations, administration, and partnerships in support of key strategic growth initiatives.

Lon Cardon

Ph.D., FMedSci

President and CEO

Responsible for the Laboratory’s global vision, strategic direction, research and operations

Mary Dickinson

Ph.D.

Executive Vice President and Chief Scientific Officer

Mary Dickinson, Ph.D. is the executive vice president and chief scientific officer at The Jackson Laboratory (JAX). She leads JAX’s research enterprise, overseeing scientific strategy and operations to build on JAX’s unique strengths in genetics and genomics. She is responsible for recruiting and retaining faculty, overseeing and seeding new initiatives and collaborations, and planning and executing the research capital budget.

Meghan Finn

Vice President and Chief Communications Officer

Responsible for developing communications strategies to raise the institution’s brand, reputation and visibility to increase support for its mission and goals.

Andy Greene

Ph.D.

Senior Vice President of Research and Professor

Studies the role of progenitor cells in cardiovascular remodeling. Develops tools for research in Protein Science.

Dan Hoag

Senior Vice President, General Counsel and Corporate Secretary

Responsible for ensuring that the Laboratory’s activities meet all legal requirements, including overseeing compliance and regulatory activities and facilitating commercial transactions, sponsored research agreements and JAX’s intellectual property matters.

James Keck

Vice President, Innovation and Product Development

Working to expand the utility of the humanized NSG platform to other therapeutic areas including autoimmune and inflammatory diseases

Mitchell Kennedy

Executive Vice President, JAX & President, JMCRS

Responsible for all functions and operational groups in JMCRS

Cathleen Lutz

Ph.D., M.B.A.

Vice President, Rare Disease Translational Center

Researches mice as a model for human neurodegenerative disease, with an emphasis on best practices for research and preclinical drug testing.

Melanie Moon

Vice President, Global Commercial Operations

Leads global commercial operations, including sales, marketing, customer service, logistics and technical support.

Martha Munhall

Vice President, Human Resources

Karolina Palucka

M.D., Ph.D.

Professor, Director, JAX Cancer Center, Edison T. Liu Endowed Chair in Cancer Research

Conducts research to understand how vaccines work and to define precisely the immune mechanisms that underlie vaccination, with a focus on cancer immunotherapies.

Jens Rueter

M.D.

Chief Medical Officer, JAX; Medical Director, MCGI

Rueter is the Chief Medical Officer of JAX, Medical Director of MCGI, and Associate Director for Translational Education at JAX Cancer Center. Rueter provides direction, leadership, and strategy for JAX’s translational and clinical research activities and clinically-oriented operations.

Gina Rodriguez

Senior Vice President of Advancement

Rodriguez leads the Laboratory’s advancement strategy and team in support of JAX’s mission to improve human health.

Nadia Rosenthal

Ph.D., FMedSci, FAAHMS

Scientific Director and Professor, The Jackson Laboratory for Mammalian Genetics, the Maxine Groffsky Endowed Chair

Investigates the role of genetic variation and the immune system in tissue repair, focusing on cardiovascular and skeletal muscle disease

Emily Schorer

Senior Vice President, Chief of Staff and Chief People Officer

Schorer serves as a strategic partner to the CEO and oversees growth initiatives, human resources, environmental health and safety services, inclusion and belonging, ombuds office and communications and marketing.

Eduardo Teixeiras

Vice President, JMCRS Operations

Eduardo is a skilled and enthusiastic leader with over 15 years of experience in leadership positions across the FMCG and pharmaceutical industries. Before joining JAX, he was a site director at GSK and Haleon for almost a decade where he successfully transformed the site's cultures through his exceptional leadership skills.

Aubrey Watkins

Ph.D., M.S.

David Shaw Family Endowed Vice President of Corporate Development

Responsible for leading corporate development initiatives, including business opportunities, faculty innovation initiatives, connections with prospective partners and exploration of potential customers and business models to amplify JAX’s global presence.

Brett Witham

Vice President, Deputy General Counsel and JMCRS General Counsel

Serves as Deputy General Counsel and Assistant Secretary to the Board of Trustees, as well as General Counsel to JAX®Mice, Clinical & Research Services.

Charlie Wray

Ph.D.

Vice President for Education

Provides direction and strategic leadership for training programs for undergraduates, graduate students, post-doctoral fellows at JAX and for educational offerings for young scientists, teachers, professors and healthcare professionals.